AlphaCrest Capital Management’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-32,936
Closed -$971K 790
2022
Q3
$971K Sell
32,936
-35,585
-52% -$1.12M 0.06% 633
2022
Q2
$1.93M Buy
68,521
+48,671
+245% +$1.39M 0.09% 325
2022
Q1
$619K Sell
19,850
-61,676
-76% -$1.82M 0.03% 791
2021
Q4
$2.41M Sell
81,526
-7,450
-8% -$218K 0.09% 332
2021
Q3
$2.67M Buy
88,976
+5,611
+7% +$193K 0.14% 186
2021
Q2
$3.02M Buy
83,365
+8,359
+11% +$310K 0.13% 209
2021
Q1
$2.75M Buy
75,006
+38,367
+105% +$1.41M 0.15% 162
2020
Q4
$1.33M Sell
36,639
-4,420
-11% -$150K 0.11% 228
2020
Q3
$1.23M Buy
41,059
+18,428
+81% +$575K 0.13% 195
2020
Q2
$673K Buy
22,631
+7,871
+53% +$233K 0.11% 264
2020
Q1
$392K Sell
14,760
-3,194
-18% -$121K 0.05% 678
2019
Q4
$760K Buy
+17,954
New +$760K 0.06% 510
2019
Q3
Sell
-14,412
Closed -$530K 1306
2019
Q2
$530K Buy
14,412
+3,254
+29% +$119K 0.05% 678
2019
Q1
$426K Buy
11,158
+2,558
+30% +$94.8K 0.06% 534
2018
Q4
$302K Buy
+8,600
New +$298K 0.09% 449

Other funds holding OHI

AlphaCrest Capital Management's OHI Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Omega Healthcare (OHI) in Q4 2022, closing a stake of 32,936 shares — an estimated $971K sold.

AlphaCrest Capital Management first reported a position in OHI in Q4 2018 and held it in 15 quarters. The position peaked at $3.02M in Q2 2021. 516 funds tracked by Wall St. Rank hold OHI as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Omega Healthcare position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 32,936 Omega Healthcare shares in Q4 2022, an estimated $971K.
  • AlphaCrest Capital Management first reported a position in Omega Healthcare in Q4 2018 and held it in 15 quarters.
  • AlphaCrest Capital Management's Omega Healthcare position peaked at $3.02M in Q2 2021.
  • 516 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.